Maitake (Grifola frondosa), commonly known in the West as “Hen of the Woods,” is a colossal and beautiful mushroom that grows at the base of large oak trees. During feudal Japan, it was a closely guarded secret by herbalists, who would literally dance for joy upon finding it due to its immense therapeutic and economic value.
Today, Maitake is at the forefront of clinical mycotherapy. Its patented beta-glucans (known as D-Fraction and MD-Fraction) are featured in numerous human clinical trials for their ability to command the immune system to attack malignant tumors. Furthermore, it is arguably the strongest metabolic regulator in the Fungi kingdom, serving as a beacon of hope for patients with Type 2 Diabetes or Polycystic Ovary Syndrome (PCOS) by “unclogging” insulin resistance.
